Ignite Creation Date:
2024-05-06 @ 1:18 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03989713
Status:
TERMINATED
Last Update Posted:
2022-09-15
First Post:
2019-04-12
Brief Title:
Quizartinib and High-dose Ara-C Plus Mitoxantrone in RelapsedRefractory AML With FLT3-ITD
Sponsor:
Prof Dr Richard F Schlenk
Organization:
University Hospital Heidelberg
Organization Data
Organization:
University Hospital Heidelberg
Class:
OTHER
Study ID:
HeLeNe-18-03-545
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Prof Dr Richard F Schlenk
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Dr Richard F Schlenk
Responsible Party Title:
Head of NCT trials center and Clinical Trials Office HematologyOncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University Hospital Heidelberg
Old Name:
None
Old Organization:
None